Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

CDC: Recommendations on the Use of Heplisav-B Published

CDC: Recommendations on the Use of Heplisav-B Published

By

The CDC has published ACIP recommendations regarding the use of Heplisav-B.

First Test to Identify <i>Candida auris</i> Gets FDA Approval

First Test to Identify Candida auris Gets FDA Approval

By

The Bruker Maldi system is already cleared for use in identifying 333 species or species groups, including 424 bacteria and yeast species.

Efficacy of Adjuvanted vs Conventional Quadrivalent Flu Vaccine Compared

Efficacy of Adjuvanted vs Conventional Quadrivalent Flu Vaccine Compared

By

MF59 adjuvanted, quadrivalent influenza vaccine (aQIV) was found to be more efficacious in preventing influenza than a non-adjuvanted conventional influenza vaccine in children aged 6 through 23 months.

MenACWY-TT Vaccine Evaluated in Patients With Anatomic/Functional Asplenia

MenACWY-TT Vaccine Evaluated in Patients With Anatomic/Functional Asplenia

By

Study evaluated the immunogenicity and safety of 1 and 2 doses of the quadrivalent meningococcal serogroups A, C, W, Y tetanus toxoid-conjugate vaccine in individuals with functional or anatomic asplenia.

Omadacycline Granted Priority Review for CABP, Skin/Skin Structure Infections

Omadacycline Granted Priority Review for CABP, Skin/Skin Structure Infections

By

Omadacycline met all required FDA and European Medicines Agency primary endpoints in each study and demonstrated a generally safe and well-tolerated profile.

More Articles by Da Hee Han, PharmD

Sign Up for Free e-newsletters